Product Specialists are available
Mon-Fri 9am-5pm MST
Call or Text:
In a recent case study published in the International Journal of Mental Health Systems, researchers set out to compare the costs of psychiatric care and hospitalizations to the cost of using micronutrient therapy to control symptoms and improve quality of life.The case study, which followed an American female adult for 5 years, yielded staggering results: the cost of hospitalization for psychiatric treatment alone cost more than 10 times the cost of micronutrients on an annual basis during the 5-year period examined. On the other hand, while taking micronutrients, the patient was stable enough to avoid the substantial costs of hospitalization, medications and psychiatric appointments.Multiple studies have demonstrated successful remission of psychosis symptoms using broad-spectrum micronutrients. This and an earlier study have now measured the economic impact of treating mental health problems using broad-spectrum micronutrients. A previous study concluded that micronutrient treatment cost about 2% of inpatient mental healthcare. The United States spent an estimated $201 billion on mental health disorders in 2013, according to a new analysis published in Health Affairs, a leading health policy journal.
That makes mental illness the costliest medical condition in the country, costing even more than cancer. What's more, the annual cost of mental healthcare in the U.S. is up nearly 200% since 2006.
But what about those without insurance?
According to the National Institute of Mental Health, in 2012 and 2013, 18 percent of adults (roughly 1 in 5) with a mental health diagnosis in the U.S. were uninsured, an increase over previous years. 
Many uninsured Americans are facing the rising cost of mental healthcare without the ability to pay. Going without treatment can have detrimental consequences for those suffering with mental health disorders, including debilitating social impacts. 
This epidemic affects children as well: 64 percent of youth with depression do not receive any treatment, whether they are insured or not. Even among those with severe depression, 63 percent do not receive any outpatient services. Only 22 percent of youth with severe depression receive any kind of consistent outpatient treatment (7-25+ visits in a year).
The study found that the cost of conventional psychiatric care was astronomically higher than the cost of using research-backed micronutrients. Don't forget: the economic impact reaches further than the patient. The increasing strain on the mental health care system as a whole affects insurance premiums, research funding, treatment costs and has widespread tax consequences.
In the concluding text of the case study, Dr. Bonnie Kaplan writes, "The patient’s annual mental health hospitalization costs during conventional treatment averaged $59,864 across 5 years (1997–2001), with a peak annual cost of about $140,000. Since transitioning to broad-spectrum micronutrients, she has incurred no hospitalization costs for mental health care, though her self-funded costs are currently $720/year for the micronutrients." There are now more than 30 independent medical journal publications demonstrating the safety and effectiveness of the micronutrients formulated† by David Hardy, founder of Hardy Nutritionals®. Hardy's hope was that his micronutrient formulations would be the first line of defense against mental illness--before psychiatric medications.
When all costs and consequences are taken into account, micronutrients should be considered a viable alternative to psychiatric medications. For more information on using clinical micronutrients to successfully treat mental health conditions, visit Try.GetHardy.com.
†Includes pre-2013 versions of EMPowerplus co-formulated by Hardy Nutritionals® Founder David L. Hardy.